Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
HLN · against 1,372 other Healthcare companies
Ranked #840 of 1,373 · scores higher than 39% of peers · safety percentile 39
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 30–39, including HLN · Click a bar to see the companies
A mix: stronger beta, but weaker current ratio and debt / equity than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | HLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.50× | 0.24× | 32% | 33% | |
| BetaLower is better · 1,320 reported | 0.24 | 0.53 | 73% | 33% | |
| Current ratioHigher is better · 1,338 reported | 0.69× | 2.62× | 3% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 836 | 4.4B USD | 39 | 66 | |
| 837 | 57.0B INR (≈$684M) |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 39 |
| 40 |
| 838 | 22.6B USD | 39 | 59 |
| 839 | 2.1B CNY (≈$301M) | 39 | 21 |
| 840 | 38.9B USD | 39 | 56 |
| 841 | 672.6B KRW (≈$484M) | 39 | 69 |
| 842 | 360M USD | 39 | 67 |
| 843 | 12.8B CNY (≈$1.8B) | 39 | 36 |
| 844 | 641.4B USD | 39 | 59 |